[1] Rahman S. Mitochondrial disease in children[J]. J Intern Med, 2020, 287:609-633. [2] Ikawa M, Okazawa H, Yoneda M. Molecular imaging for mitochondrial metabolism and oxidative stress in mitochondrial diseases and neurodegenerative disorders[J]. Biochim Biophys Acta Gen Subj, 2021, 1865:129832. [3] Mascalchi M, Montomoli M, Guerrini R. Neuroimaging in mitochondrial disorders[J]. Essays Biochem, 2018, 62:409-421. [4] Gonçalves FG, Alves CAPF, Heuer B, Peterson J, Viaene AN, Reis Teixeira S, Martín-Saavedra JS, Andronikou S, Goldstein A, Vossough A. Primary mitochondrial disorders of the pediatric central nervous system:neuroimaging findings[J]. Radiographics, 2020, 40:2042-2067. [5] Pichon L, Ivanoiu A, Duprez T, Lacomblez D, Wilms G. NEURO-IMAGE:MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome)[J]. Acta Neurol Belg, 2021.[Epub ahead of print] [6] Cheng W, Zhang Y, He L. MRI features of stroke-like episodes in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes[J]. Front Neurol, 2022, 13:843386. [7] Fine AS, Nemeth CL, Kaufman ML, Fatemi A. Mitochondrial aminoacyl-tRNA synthetase disorders:an emerging group of developmental disorders of myelination[J]. J Neurodev Disord, 2019, 11:29. [8] Finsterer J, Zarrouk-Mahjoub S. Cerebral imaging in paediatric mitochondrial disorders[J]. Neuroradiol J, 2018, 31:596-608. [9] Finsterer J, Zarrouk-Mahjoub S. Cerebellar atrophy is common among mitochondrial disorders[J]. Metab Brain Dis, 2018, 33:987-988. [10] Rahman S, Copeland WC. POLG-related disorders and their neurological manifestations[J]. Nat Rev Neurol, 2019, 15:40-52. [11] Blanc C, Heran F, Habas C, Bejot Y, Sahel J, Vignal-Clermont C. MRI of the optic nerves and chiasm in patients with leber hereditary optic neuropathy[J]. J Neuroophthalmol, 2018, 38:434-437. [12] Luca P, Alessia G, Camilla RM, Antonio N, Diego M, Federica D, Daria D, Rosalba C, Carlo DV, Daniela L. Spinal cord involvement in Kearns-Sayre syndrome:a neuroimaging study[J]. Neuroradiology, 2020, 62:1315-1321. [13] Finsterer J, Zarrouk-Mahjoub S. Involvement of the spinal cord in mitochondrial disorders[J]. J Neurosci Rural Pract, 2018, 9:245-251. [14] Finsterer J. Spinal cord involvement in Leigh syndrome[J]. Brain Dev, 2018, 40:733-734. [15] Nassif DV, Vasconcellos LFR. Proton spectroscopy:a simple and useful tool in the investigation of mitochondrial disease[J]. Arq Neuropsiquiatr, 2022, 80:543-544. [16] Wang R, Hu B, Sun C, Geng D, Lin J, Li Y. Metabolic abnormality in acute stroke-like lesion and its relationship with focal cerebral blood flow in patients with MELAS:evidence from proton MR spectroscopy and arterial spin labeling[J]. Mitochondrion, 2021, 59:276-282. [17] Alves CAPF, Teixeira SR, Martin-Saavedra JS, Guimarães Gonçalves F, Lo Russo F, Muraresku C, McCormick EM, Falk MJ, Zolkipli-Cunningham Z, Ganetzky R, Vossough A, Goldstein A, Zuccoli G. Pediatric leigh syndrome:neuroimaging features and genetic correlations[J]. Ann Neurol, 2020, 88:218-232. [18] Stenton SL, Zou Y, Cheng H, Prokisch H, Fang F. Pediatric leigh syndrome:neuroimaging features and genetic correlations[J]. Ann Neurol, 2021, 89:629-631. [19] Miyauchi A, Osaka H, Nagashima M, Kuwajima M, Monden Y, Kohda M, Kishita Y, Okazaki Y, Murayama K, Ohtake A, Yamagata T. Leigh syndrome with spinal cord involvement due to a hemizygous NDUFA1 mutation[J]. Brain Dev, 2018, 40:498-502. [20] Rare Diseases Branch, Beijing Medical Association; Neuromuscular Disease Group, Neurology Branch, Beijing Medical Association; China National Research Collaborative Group on Mitochondrial Disease. Chinese expert consensus on diagnosis and treatment of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes[J]. Zhonghua Shen Jing Ke Za Zhi, 2020, 53:171-178.[北京医学会罕见病分会, 北京医学会神经内科分会神经肌肉病学组, 中国线粒体病协作组.中国线粒体脑肌病伴高乳酸血症和卒中样发作的诊治专家共识[J].中华神经科杂志, 2020, 53:171-178.] [21] Hovsepian DA, Galati A, Chong RA, Mazumder R, DeGiorgio CM, Mishra S, Yim C. MELAS:monitoring treatment with magnetic resonance spectroscopy[J]. Acta Neurol Scand, 2019, 139:82-85. [22] Jha R, Patel H, Dubey R, Goswami JN, Bhagwat C, Saini L, K Manokaran R, John BM, Kovilapu UB, Mohimen A, Saxena A, Sondhi V. Clinical and molecular spectrum associated with Polymerase-γ related disorders[J]. J Child Neurol, 2022, 37:246-255. [23] Gonçalves FG, Hill B, Guo Y, Muraresku CC, McCormick E, Alves CAPF, Teixeira SR, Martin-Saavedra JS, Zolkipli-Cunningham Z, Falk MJ, Vossough A, Goldstein A, Zuccoli G. The perirolandic sign:a unique imaging finding observed in association with polymerase γ-related disorders[J]. AJNR Am J Neuroradiol, 2020, 41:917-922. [24] Moscatelli M, Ardissone A, Lamantea E, Zorzi G, Bruno C, Moroni I, Erbetta A, Chiapparini L. Kearns-Sayre syndrome:expanding spectrum of a "novel" mitochondrial leukomyeloencephalopathy[J]. Neurol Sci, 2022, 43:2081-2084. [25] Ahn YJ, Park Y, Shin SY, Chae H, Kim M, Park SH. Genotypic and phenotypic characteristics of Korean children with childhood-onset Leber's hereditary optic neuropathy[J]. Graefes Arch Clin Exp Ophthalmol, 2020, 258:2283-2290. [26] Stellingwerff MD, Figuccia S, Bellacchio E, Alvarez K, Castiglioni C, Topaloglu P, Stutterd CA, Erasmus CE, Sanchez-Valle A, Lebon S, Hughes S, Schmitt-Mechelke T, Vasco G, Chow G, Rahikkala E, Dallabona C, Okuma C, Aiello C, Goffrini P, Abbink TEM, Bertini ES, Van der Knaap MS. LBSL:case series and DARS2 variant analysis in early severe forms with unexpected presentations[J]. Neurol Genet, 2021, 7:e559. [27] Han XD, Fang F, Li H, Liu ZM, Shi YQ, Wang JL, Ren XT, Ding CH, Chen CH, Li JW, Zhang WH, Deng J. Clinical and genetic characteristics of 62 children with mitochondrial epilepsy[J]. Zhonghua Er Ke Za Zhi, 2019, 57:844-851. [28] Stenton SL, Zou Y, Cheng H, Liu Z, Wang J, Shen D, Jin H, Ding C, Tang X, Sun S, Han H, Ma Y, Zhang W, Jin R, Wang H, Sun D, Lv JL, Prokisch H, Fang F. Leigh syndrome:a study of 209 patients at the Beijing Children's Hospital[J]. Ann Neurol, 2022, 91:466-482. [29] Matilainen S, Isohanni P, Euro L, Lönnqvist T, Pihko H, Kivelä T, Knuutila S, Suomalainen A. Mitochondrial encephalomyopathy and retinoblastoma explained by compound heterozygosity of SUCLA2 point mutation and 13q14 deletion[J]. Eur J Hum Genet, 2017, 25:393. [30] Hu C, Li X, Zhao L, Shi Y, Zhou S, Wu B, Wang Y. Clinical and molecular characterization of pediatric mitochondrial disorders in south of China[J]. Eur J Med Genet, 2020, 63:103898. [31] Mazzoleni V, Grassi M, Lodigiani C, Rasura M, Zedde M, Gandolfo C, Zini A, DeLodovici ML, Paciaroni M, Del Sette M, Toriello A, Musolino R, Calabrò RS, Bovi P, Giossi A, Adami A, Silvestrelli G, Cavallini A, Marcheselli S, Bonifati DM, Checcarelli N, Tancredi L, Chiti A, Giorli E, Pezzini D, Locatelli M, Bonacina S, Giacalone G, Volta GD, Magoni M, Cerrato P, Bignamini V, Micieli G, Melis M, Sanguigni S, Braga M, Padovani A, Pezzini A; Italian Project on Stroke in Young Adults Investigators. Migraine and cryptogenic ischemic stroke[J]. Ann Neurol, 2021, 89:627-629. [32] Haast RAM, Ivanov D, IJsselstein RJT, Sallevelt SCEH, Jansen JFA, Smeets HJM, de Coo IFM, Formisano E, Uludağ K. Anatomic and metabolic brain markers of the m. 3243A > G mutation:a multi-parametric 7T MRI study[J]. Neuroimage Clin, 2018, 18:231-244. [33] Ikawa M, Okazawa H, Nakamoto Y, Yoneda M. PET imaging for oxidative stress in neurodegenerative disorders associated with mitochondrial dysfunction[J]. Antioxidants (Basel), 2020, 9:861. |